Sun Pharma Launches New Ad Campaign to Raise Awareness of Acne and its Impact on Everyday Life

Sun Pharma

Drug Development

ILUMYA™ (tildrakizumab-asmn) 3-Year Data Demonstrates Sustained Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis

Sun Pharma

Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone

Sun Pharma